Analysis of tumor-infiltrating CD45+ leukocytes showed consistent Lov-mediated upregulation of IFNγ and IL-1β (M1 markers) and downmodulation of IL-10, CD206 and CCL22 (M2 markers). This evidence concerns the gene PTPRC and neoplasm.